6-118479910-GCTGT-G
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 8P and 1B. PVS1BS2_Supporting
The NM_001042475.3(CEP85L):c.1871_1874delACAG(p.Asp624AlafsTer9) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000182 in 1,486,204 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000046 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000015 ( 0 hom. )
Consequence
CEP85L
NM_001042475.3 frameshift
NM_001042475.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 3.07
Genes affected
CEP85L (HGNC:21638): (centrosomal protein 85 like) The protein encoded by this gene was identified as a breast cancer antigen. Nothing more is known of its function at this time. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
BS2
High AC in GnomAd4 at 7 AD gene. Variant has AC lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEP85L | ENST00000368491.8 | c.1871_1874delACAG | p.Asp624AlafsTer9 | frameshift_variant | Exon 10 of 13 | 1 | NM_001042475.3 | ENSP00000357477.3 | ||
CEP85L | ENST00000368488.9 | c.1880_1883delACAG | p.Asp627AlafsTer9 | frameshift_variant | Exon 11 of 14 | 5 | ENSP00000357474.5 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151980Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
7
AN:
151980
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000300 AC: 6AN: 200052Hom.: 0 AF XY: 0.0000274 AC XY: 3AN XY: 109590
GnomAD3 exomes
AF:
AC:
6
AN:
200052
Hom.:
AF XY:
AC XY:
3
AN XY:
109590
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000150 AC: 20AN: 1334224Hom.: 0 AF XY: 0.0000165 AC XY: 11AN XY: 667108
GnomAD4 exome
AF:
AC:
20
AN:
1334224
Hom.:
AF XY:
AC XY:
11
AN XY:
667108
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151980Hom.: 0 Cov.: 32 AF XY: 0.0000539 AC XY: 4AN XY: 74222
GnomAD4 genome
AF:
AC:
7
AN:
151980
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74222
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Lissencephaly 10 Uncertain:1
Nov 22, 2021
Revvity Omics, Revvity
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at